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Certain strains of Shiga toxin-producing Escherichia coli (STEC) which do not have the locus of enterocyte
effacement pathogenicity island carry the STEC autoagglutinating adhesin (saa) gene. The distribution of the
saa gene in STEC isolates from patients with hemolytic-uremic syndrome (HUS), patients with less severe
diarrheal disease, asymptomatic individuals, and healthy cattle was examined. saa-positive strains were
detected more frequently (P < 0.001) in STEC strains from bovines (32 of 56 strains) than in those from
humans (8 of 91 strains). No significant association (P  0.135) was found between the saa gene and STEC
isolated from patients with HUS (6 of 46 strains) or diarrhea (2 of 29 strains) and from healthy controls (0 of
16 strains).
Shiga toxin-producing Escherichia coli (STEC), also referred
to as verocytotoxin-producing E. coli, cause a broad spectrum
of disease in humans ranging from mild diarrhea to severe
disease, such as hemorrhagic colitis and hemolytic-uremic syn-
drome (HUS) (2, 8, 20). A wide range of STEC serogroups can
cause human disease, although the most commonly isolated
serogroups from patients infected with STEC, notably O26,
O103, O111, O145, and O157 (16, 21), are those harboring the
locus of enterocyte effacement (LEE) (4). One of the genes
located on the LEE is eae (E. coli attaching and effacing),
which encodes intimin, an outer membrane protein involved in
intimate attachment of the bacteria to intestinal host cells (4).
However, the presence of the LEE is not essential for patho-
genesis, as a number of cases of severe STEC disease, includ-
ing HUS, have been caused by LEE-negative strains (6, 9, 12).
Paton et al. recently described a novel autoagglutinating ad-
hesin, designated Saa (STEC autoagglutinating adhesin), in a
LEE-negative O113:H21 STEC strain responsible for an out-
break of HUS (13). Those authors presented evidence that the
saa gene was plasmid encoded and associated with the STEC
enterohemolysin genes (13, 14). The saa gene was also de-
tected in certain other STEC isolates from humans, including
other LEE-negative strains isolated from sporadic HUS cases
(14). This raised the possibility that Saa might be a virulence
factor for virulent LEE-negative STEC in humans, but there
were insufficient numbers of strains available for testing to
draw any firm conclusions. In the present study, we examined
the distribution of the saa gene in a large collection of STEC
isolates from patients with HUS and diarrheal disease and
from a healthy control group to test whether there is any
association between the presence of saa and severe human
STEC disease. We also investigated the distribution of the saa
gene in isolates from healthy cattle in the United Kingdom to
determine whether this gene may be associated with bovine
STEC.
The 91 strains of STEC from the culture collection of the
Laboratory of Enteric Pathogens (LEP), London, United
Kingdom, comprised 46 strains from patients with HUS (Table
1), 29 isolated from patients with diarrhea who did not develop
HUS (Table 2), and 16 from a healthy control group (Table 3)
(3, 8, 16, 18, 19). Sixty-one of these strains were differentiated
by serotyping, stx typing, and the presence or absence of the eae
and STEC enterohemolysin (ehxA) genes (5, 11, 15, 17). The
strains were isolated between 1983 and 2000 either at the LEP
from fecal samples submitted for detection of STEC or at
hospital laboratories and then sent to the LEP for confirmation
and further tests. Fecal pat samples collected from healthy
cattle from 41 different farms in Scotland between 1996 and
1999 were examined for the presence of STEC strains other
than those belonging to serogroup O157 (7). Fifty-six STEC
strains were isolated from 423 fecal samples; 30 of these strains
were differentiated by serotyping, stx typing, and the presence
or absence of the eae and ehxA genes (5, 11, 15, 17) (Table 4).
These strains were tested for the presence of saa by PCR with
primers 5-CGTGATGAACAGGCTATTGC and 5-ATGGA
CATGCCTGTGGCAAC, which amplify a 119-bp portion of
the saa gene (14). To test for differences in the detection of
particular genes between the four groups of strains, general-
ized linear models with binomial errors were performed. In all
cases, a P value of 0.05 was taken to indicate significance.
Fisher’s exact tests were performed to test the significance of
the association between the detection of particular genes.
Forty (27%) of the 147 STEC strains in this study had the
saa gene (Tables 1-3). None of these 40 saa-positive strains
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carried the eae gene, and 39 were ehxA positive; the excep-
tional strain (saa positive and ehxA negative) belonged to se-
rotype O128ab:H8 (Table 2). The saa gene was detected in 6
(13%) of 46 strains from humans with HUS, and 28 (61%) of
these 46 strains carried the eae gene, while 12 (26%) had
neither (Table 1). Two (7%) of 29 strains from patients with
diarrhea or bloody diarrhea who did not develop HUS were
saa positive. The eae gene was detected in 10 (34%) strains
from this group, and 17 (59%) had neither the eae nor the saa
gene (Table 2). None of the isolates from the healthy control
group had the saa gene (Table 3). Characterization of the 56
bovine strains showed that 32 (57%) carried the saa gene, 2
(4%) were eae positive, and 22 (39%) were negative for both
eae and saa (Table 4). None of the strains harboring the saa
gene had the eae gene.
Statistical analysis revealed a significant difference in the
frequencies of saa-positive strains between the four groups (2
 45.45; df  3; P  0.001). However, if the cattle strains are
excluded from the analysis, then this significance was lost (2 
4.00; df  2; P  0.135). Therefore, the number of cattle
strains containing the saa gene is significantly higher than the
number of saa-positive human strains, although there is no
difference in the presence of the saa gene between the strains
from patients with HUS, patients with diarrhea, and the
asymptomatic individuals. Statistical tests also showed a signif-
icant difference in the frequencies of isolates containing the eae
gene between the four groups (2  55.89; df  3; P  0.001),
with the highest frequency of intimin-positive strains being
found in the HUS group.
Variables over and above the group categories (HUS, diar-
rhea, healthy control, and cattle strains), such as toxin type and
the presence of the eae and ehxA genes, and the fact that
certain serotypes are represented by more strains than are
others may influence the results. However, the panel of strains
reflects the fact that some serotypes associated with HUS (e.g.,
O26:H11) or less severe diarrhea (e.g., O128ab:H2) are more
commonly isolated than others (2, 9, 16, 20, 21). To date, the
saa gene has not been found in STEC strains harboring the eae
TABLE 1. Characterization of non-O157 STEC strains isolated
from HUS patientsa
Serotype (no. of strains)b stx genetype
Presence or absence of:
eae ehxA saa
O2:H6 (1) 2   
O5:H- (1) 1   
O9ab:H- (1) 2   
O26:H- (1) 2   
O26:H- (1) 1   
O26:H11 (1) 2   
O26:H11 (3) 1   
O55:H7 (1) 2   
O55:H10 (1) 2   
O91:H21 (1) 2   
O104:H2 (1) 2   
O105ac:H18 (1) 12   
O111ac:H- (2) 1   
O111ac:H- (5) 12   
O113:H4 (1) 2   
O115:H10 (1) 1   
O121:H19 (1) 2   
O128ab:H2 (1) 12   
O128ab:H7 (1) 2   
O128ab:H25 (1) 2   
O134:H25 (1) 2   
O145:H- (1) 1   
O145:H25 (5) 2   
O153:H25 (1) 2   
O163:H19 (2) 2   
O165:H25 (2) 2   
O168:H- (1) 2   
O172:H- (1) 2   
O173:H21 (1) 2   
O?:H4 (1)c 2   
O?:H21 (2) 2   
O?:H40 (1) 2   
a See references 9, 18, 19, 20, and 21.
b Where the serotype is the same, isolates have been differentiated according
to stx type and the presence or absence of the eae and ehxA genes.
c O?, could not be serogrouped using the current serotyping scheme.
TABLE 2. Characterization of non-O157 STEC strains isolated
from patients with diarrhea but who did not develop HUSa
Serotype (no. of strains) stx genetype
Presence or absence of:
eae ehxA saa
O4:H10 (1) 12   
O5:H- (2) 1   
O26:H11 (5) 1   
O76:H7 (1) 2   
O91:H- (1) 12   
O105ac:H18 (1) 12   
O118:H12 (3) 2   
O121:H19 (1) 2   
O128ab:H- (2) 12   
O128ab:H2 (6) 12   
O128ab:H8 (1) 12   
O?:H- (1)b 1   
O?:H10 (1) 2   
O?:H19 (1) 1   
Orough:H- (1) 2   
Orough:H45 (1) 2   
a See references 9, 18, 19, 20, and 26.
b O?, could not be serogrouped using the current serotyping scheme.
TABLE 3. Strains of non-O157 STEC isolated from a healthy
control group during a study of infectious intestinal diseasea
Serotype (no. of strains) stx genetype
Presence or absence of:
eae ehxA saa
O82:H2 (1) 12   
O91:H- (1) 1   
O91:H10 (1) 2   
O115:H10 (1) 1   
O118:H1 (1) 2   
O128ab:H2 (3) 12   
O146:H21 (2) 12   
O162:H6 (1) 12   
O162:H8 (1) 12   
O?:H- (1)b 2   
O?:H- (1) 12   
O?:H18 (1) 12   
O?:H21 (1) 1   
a See reference 3.
b O?, could not be serogrouped using the current serotyping scheme.
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gene, and the association of saa with bovine strains may be due
to the fact that there are so few intimin-positive strains in this
group. However, statistical analysis of only the intimin-nega-
tive strains showed that there was still a significantly higher
frequency of saa-positive strains in STEC strains from cattle
than in those from humans (P  0.001, Fisher’s exact test).
Thirty-nine of 40 (98%) saa-positive strains also carried the
ehxA genes, and 39 of 51 (76%) strains that were negative for
the saa and eae genes were also negative for the ehxA gene.
Tests showed that for the eae-negative strains, there was a
significant association between the presence of the saa and
ehxA genes (P  0.001, Fisher’s exact test). These results are
consistent with the observation of Paton et al. that the saa gene
is plasmid encoded and associated with the plasmid-encoded
ehxA gene (13). Only one strain of serotype O128ab:H8 was
saa positive but ehxA negative, and further work is being car-
ried out to determine whether the saa gene is plasmid encoded
in this strain.
The only saa-positive serotype common to both human and
bovine STEC strains in this study was O105ac:H18. Carriage of
the saa gene appeared to be specific to certain serotypes within
a serogroup, e.g., O113:H21 was saa positive, whereas
O113:H4 was saa negative. Of the 22 bovine serotypes that
have yet to be designated as a formal “O” type (i.e., provisional
types and “O?”), 13 carried the saa gene. This highlights the
need to extend the serotyping scheme to include new and
emerging STEC serogroups.
Our results showed that there was no significant association
between strains of STEC isolated from patients with HUS and
the saa gene, although they do support the suggestion that the
eae gene is detected more frequently in STEC from this group
of patients (1, 10). However, the saa gene was significantly
associated with bovine STEC strains, suggesting that Saa may
have a role in attachment to the bovine gut. Further work is
being carried out, both in vitro and in vivo, to examine the role
of Saa in attachment to the bovine gut mucosa.
Fecal pat samples were collected as part of the study “Determina-
tion of the Prevalence of E. coli O157 in Scottish Beef Cattle” funded
by the Scottish Executive Environment and Rural Affairs Department.
Bovine STEC were isolated as part of the International Partnership
Research Award in Veterinary Epidemiology project entitled “Epide-
miology and Evolution of Enterobacteriaceae Infections in Humans and
Domestic Animals” funded by the Wellcome Trust.
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